Month: March 2023

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2023.03.29

Presentation – Genomtec’s development plans and the status of the M&A process

We invite you to watch the webinar and chat with Genomtec’s Management Board, which took place on Strefa Inwestorów on Wednesday, March 29. ...
Read
2023.03.22

Webinar with the Management Board of Genomtec

A webinar with Genomtec Management Board organized by the Warsaw Stock Exchange will be held on Friday, March 24, at 4:00 pm. Link to the ...
Read
2023.03.21

Genomtec wants the Shareholders to participate in the benefits of the potential M&A transaction to the largest possible extent

According to the adopted resolution, the Issuer’s Management Board will take all reasonable steps to ensure the Shareholders’ ...
Read
2023.03.07

Puls Biznesu: Genomtec wants to strengthen with a share issue

In February, the company announced plans for a share issue of up to 1.64 million shares, which will represent 14 percent of the company’s ...
Read

Archive